Paratek Pharmaceuticals
PRTK
#9534
Rank
โ‚น12.22 B
Marketcap
โ‚น213.34
Share price
0.00%
Change (1 day)
26.94%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -โ‚น3.58 Billion

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.16 Billion. In 2022 the company made an earning of -โ‚น4.35 Billion a decrease over its 2021 earnings that were of -โ‚น3.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚น3.58 Billion-17.58%
2022 -โ‚น4.35 Billion10.5%
2021 -โ‚น3.93 Billion-46.16%
2020 -โ‚น7.3 Billion-31.93%
2019 -โ‚น10.73 Billion11.12%
2018 -โ‚น9.66 Billion21.19%
2017 -โ‚น7.97 Billion-23.22%
2016 -โ‚น10.38 Billion54.68%
2015 -โ‚น6.71 Billion309.5%
2014 -โ‚น1.64 Billion-29.88%
2013 -โ‚น2.34 Billion
2011 -โ‚น0.37 Billion-59.18%
2010 -โ‚น0.89 Billion-53.53%
2009 -โ‚น1.9 Billion-161.93%
2008 โ‚น3.06 B-187.43%
2007 -โ‚น3.51 Billion11.93%
2006 -โ‚น3.14 Billion31.69%
2005 -โ‚น2.38 Billion32.4%
2004 -โ‚น1.8 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚น51.34 Billion 1,127.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น5.93 Billion 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น11.44 B-373.73%๐Ÿ‡บ๐Ÿ‡ธ USA